Sigilon Therapeutics, Inc. Annual Operating Margin in % from 2020 to 2022

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Sigilon Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from 2020 to 2022.
  • Sigilon Therapeutics, Inc. Operating Margin for the quarter ending June 30, 2023 was -175 %, a 73% increase year-over-year.
  • Sigilon Therapeutics, Inc. annual Operating Margin for 2022 was -337 %, a 57.2% increase from 2021.
  • Sigilon Therapeutics, Inc. annual Operating Margin for 2021 was -788 %, a 100% decline from 2020.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2022 -337 +451 +57.2% Jan 1, 2022 Dec 31, 2022
2021 -788 -394 -100% Jan 1, 2021 Dec 31, 2021
2020 -394 Jan 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.